Article
A Pan-Cancer Analysis Reveals OAS2 as a Biomarker for Cancer Prognosis and Immunotherapy
2023-07-07
Abstract excerpt
<h4>Background: </h4> Although immunotherapy with immune checkpoint inhibitor has emerged as a remarkably effective treatment modality, it benefits only a small proportion of patients. Oligoadenylate Synthetase 2 (OAS2) has been implicated in various cancers, while the relationship between OAS2 expression, immune cell infiltration, and patient prognosis in pan-cancer remains unclear. <h4>Methods: </h4>: We conduct...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 73ec4bc2-67e5-5744-88c5-4be486eebf61
- DOI
- 10.21203/rs.3.rs-3097514/v1